ROC analysis was applied to evaluate the effectiveness of E2F2 mRNA expression level to distinguish colorectal adenocarcinoma from normal tissues, which estimated AUC at 0.865 (95% CI: 0.784-0.946, Figure 3G) in the GSE20916 data set. Here, E2F2 is linked to colorectal adenocarcinoma.